Xencor reported $12M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
Amgen USD 9.14B 432M Mar/2026
Arrowhead Research USD 15.68M 203.19M Mar/2026
AstraZeneca USD 17.88B 1.17B Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Cytokinetics USD 6.83M 10.94M Mar/2026
GlaxoSmithKline GBP 7.94B 178M Mar/2026
J&J USD 21.33B 3.72B Dec/2025
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
MacroGenics USD 13.37M 55.86M Dec/2025
Merck USD 11.78B 345M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Xencor USD 12M 17.3M Mar/2026